First Time Loading...

Theseus Pharmaceuticals Inc
NASDAQ:THRX

Watchlist Manager
Theseus Pharmaceuticals Inc Logo
Theseus Pharmaceuticals Inc
NASDAQ:THRX
Watchlist
Price: 4.06 USD Market Closed
Updated: Jun 6, 2024

Theseus Pharmaceuticals Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Theseus Pharmaceuticals Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Theseus Pharmaceuticals Inc
NASDAQ:THRX
Total Equity
$207.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Equity
$70B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$16.5B
CAGR 3-Years
-24%
CAGR 5-Years
2%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$92.3B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Total Equity
$40.4B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
-2%
Eli Lilly and Co
NYSE:LLY
Total Equity
$12.8B
CAGR 3-Years
23%
CAGR 5-Years
39%
CAGR 10-Years
-4%

See Also

What is Theseus Pharmaceuticals Inc's Total Equity?
Total Equity
207.6m USD

Based on the financial report for Dec 31, 2022, Theseus Pharmaceuticals Inc's Total Equity amounts to 207.6m USD.

What is Theseus Pharmaceuticals Inc's Total Equity growth rate?
Total Equity CAGR 1Y
-16%

Over the last year, the Total Equity growth was -16%.